Market Goldman adds J&J to its ‘conviction list.’ Here’s who else is on itBy adminMay 1, 20250 Goldman Sachs named pharmaceutical giant Johnson & Johnson to its “U.S. Conviction List – Directors’ Cut” of the most recommended…
